FRLN News and Press, Freeline Therapeutics Holdings plc From 12/05/23

Reliq Health Technologies Inc (RQHTF) is expected to report for quarter end 2023-09-30 Atento S.A. (ATTOF) is expected to report for Q3 2023 GLG Life Tech Corporation (GLGLF) is expected to report for Q1 2024 CMG Holdings Group Inc (CMGO) is expected to report for Q1 2024 Todos Me...

NEW YORK, NY / ACCESSWIRE / December 1, 2023 / Juan Monteverde , founder and managing partner of the class action firm Monteverde & Associates PC (the "M&A Class Action Firm"), a national securities firm rated Top 50 in the 2018-2022 ISS Securities Class Action Services Report and h...

NEW YORK, NY / ACCESSWIRE / November 30, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: WaveDancer, Inc. (NASDAQ:WAVD)'s ...

Please find enclosed the presentation of Frontline plc´s third quarter 2023 results to be held on the webcast / conference call 30 November, 2023 at 15:00 CET. This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act. ...

FRONTLINE PLC REPORTS RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2023 Frontline plc (the “Company” or “Frontline”), today reported unaudited results for the nine months ended September 30, 2023: Highlights Profit of $107.7 million, or $0.48 p...

Frontline plc.’s preliminary third quarter 2023 results will be released on Thursday November 30, 2023, and a webcast and conference call will be held at 3:00 p.m. CET (9:00 a.m. U.S. Eastern Time). The results presentation will be available for download from the Investor Relations section...

Frontline plc (“Frontline”) (NYSE and OSE: FRO), today announced that the sale by Frontline of 13.7 million shares in Euronav NV (“Euronav”) to CMB NV (“CMB”) has been completed. On 9 October 2023 Frontline announced that it had agreed on an integrated so...

2023-11-22 07:51:12 ET More on Freeline Therapeutics Freeline gains on non-binding buyout offer from Syncona Freeline posts early data for gene therapy in Gaucher disease Seeking Alpha’s Quant Rating on Freeline Therapeutics Historical earnings data fo...

Freeline shareholders to receive $6.50 per American Depositary Share, a 51% premium over closing price prior to announcement of Syncona’s initial proposal on October 18, in an all-cash transaction Based on extensive evaluation of available strategic and financing options, Freelin...

Freightos Limited (CRGO) is expected to report $-0.14 for Q3 2023 Magyar Telekom Telecommunications ADR (MYTAY) is expected to report for Q3 2023 IMAC Holdings Inc. (BACK) is expected to report for Q1 2024 NewJersey Resources Corporation (NJR) is expected to report $0.3 for Q4 2023 ...